Han Chong Toh
机构：National Cancer Centre Singapore · ORCID：0000-0003-0642-3453
发表论文 243 篇 · 总被引 11692 次 · h-index 53
代表论文
- Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trial (2025 · The Lancet. Gastroenterology & hepatology · 被引 35)
- Single-cell RNA sequencing reveals anti-tumor potency of CD56+ NK cells and CD8+ T cells in humanized mice via PD-1 and TIGIT co-targeting (2024 · Molecular Therapy · 被引 20)
- Serotonin receptor 5-HT 2A as a potential target for HCC immunotherapy (2025 · Journal for ImmunoTherapy of Cancer · 被引 13)
- Atypical memory B cells acquire Breg phenotypes in hepatocellular carcinoma (2025 · JCI Insight · 被引 10)
- Impact of Antibiotics and Chronic Medications on Efficacy of Immune Checkpoint Inhibitors in Patients With Hepatocellular Carcinoma (2024 · Asia-Pacific Journal of Clinical Oncology · 被引 5)
- Clonal diversity underpins distinct modes of recurrence in hepatocellular carcinoma: the PLANet cohort study (2026 · Gut · 被引 2)